Ptc Therapeutics (PTCT) EBITDA Margin Growth (5y) (2017 - 2026)
Ptc Therapeutics (PTCT) EBITDA Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,971.00 |
| Dec 31, 2025 | 4,653.00 |
| Sep 30, 2025 | 4,799.00 |
| Jun 30, 2025 | 22,936.00 |
| Mar 31, 2025 | 21,873.00 |
| Dec 31, 2024 | 1,323.00 |
| Sep 30, 2024 | 5,704.00 |
| Mar 31, 2024 | 10,869.00 |
| Dec 31, 2023 | 5,448.00 |
| Sep 30, 2023 | 3,085.00 |
| Jun 30, 2023 | 87,477.00 |
| Mar 31, 2023 | -2,346.00 |
| Dec 31, 2022 | -12,908.00 |
| Sep 30, 2022 | 4,254.00 |
| Jun 30, 2022 | -2,970.00 |
| Mar 31, 2022 | 4,150.00 |
| Dec 31, 2021 | 3.47 Mn |
| Sep 30, 2021 | 322,829.00 |
| Jun 30, 2021 | 1.86 Mn |
| Mar 31, 2021 | 12,042.00 |